AKREOS POSTERIOR CHAMBER INTRAOCULAR LENS,MODEL ADAPT

Intraocular Lens

FDA Premarket Approval P060022

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the akreos posterior chamber intraocular lens (iol), model: akreos advanced optics aspheric lens, ao60. The device is indicated for primary implantation for the visual correction of aphakia in adult patients where a cataractous lens has been removed by phacoemulsifi-cation. The lens is intended to be placed in the capsular bag.

DeviceAKREOS POSTERIOR CHAMBER INTRAOCULAR LENS,MODEL ADAPT
Classification NameIntraocular Lens
Generic NameIntraocular Lens
ApplicantBausch & Lomb, Inc.
Date Received2006-06-29
Decision Date2008-09-05
Notice Date2008-09-19
PMAP060022
SupplementS
Product CodeHQL
Docket Number08M-0515
Advisory CommitteeOphthalmic
Expedited ReviewNo
Combination Product No
Applicant Address Bausch & Lomb, Inc. 50 Technology Drive irvine, CA 92618
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P060022Original Filing
S030 2022-08-16 30-day Notice
S029 2021-12-22 30-day Notice
S028 2020-12-04 30-day Notice
S027
S026
S025 2019-12-23 30-day Notice
S024 2018-07-10 30-day Notice
S023 2016-06-03 30-day Notice
S022 2015-09-11 135 Review Track For 30-day Notice
S021 2015-02-18 30-day Notice
S020 2014-12-08 Real-time Process
S019 2014-05-15 30-day Notice
S018
S017 2013-06-10 30-day Notice
S016 2013-04-15 Real-time Process
S015 2013-02-22 30-day Notice
S014 2012-08-20 30-day Notice
S013 2012-03-20 Real-time Process
S012 2011-06-21 Normal 180 Day Track
S011 2011-05-09 30-day Notice
S010 2011-02-16 Normal 180 Day Track No User Fee
S009 2011-03-18 30-day Notice
S008 2011-03-18 135 Review Track For 30-day Notice
S007 2010-04-30 30-day Notice
S006 2010-01-29 Real-time Process
S005 2009-08-25 30-day Notice
S004 2009-03-06 30-day Notice
S003
S002 2008-10-24 Real-time Process
S001 2008-10-20 30-day Notice

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.